Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Use of Antiretroviral Drug Testing to Assess the Accuracy of Self-reported Data from HIV-Infected People Who Inject Drugs.

Fogel JM, Zhang Y, Palumbo PJ, Guo X, Clarke W, Breaud A, Richardson P, Piwowar-Manning E, Hamilton EL, Ha TV, Dumchev K, Djoerban Z, Hoffman I, Hanscom B, Miller WC, Eshleman SH.

AIDS Behav. 2019 Aug;23(8):2101-2108. doi: 10.1007/s10461-018-2379-8.

PMID:
30600453
2.

Natural control of HIV infection in young women in South Africa: HPTN 068.

Sivay MV, Fogel JM, Wang J, Zhang Y, Piwowar-Manning E, Clarke W, Breaud A, Blankson J, Hamilton EL, Kahn K, Selin A, Gomez-Olive FX, MacPhail C, Hughes JP, Pettifor A, Eshleman SH.

HIV Clin Trials. 2018 Oct;19(5):202-208. doi: 10.1080/15284336.2018.1531534. Epub 2018 Dec 6.

PMID:
30522410
3.

Accuracy of Self-Reported HIV Status Among African Men and Transgender Women Who Have Sex with Men Who were Screened for Participation in a Research Study: HPTN 075.

Fogel JM, Sandfort T, Zhang Y, Guo X, Clarke W, Breaud A, Cummings V, Hamilton EL, Ogendo A, Kayange N, Panchia R, Dominguez K, Chen YQ, Eshleman SH.

AIDS Behav. 2019 Jan;23(1):289-294. doi: 10.1007/s10461-018-2231-1.

PMID:
30051192
4.

Antiretroviral Drug Use and HIV Drug Resistance Among Young Women in Rural South Africa: HPTN 068.

Zhang Y, Sivay MV, Hudelson SE, Clarke W, Breaud A, Wang J, Piwowar-Manning E, Agyei Y, Fogel JM, Hamilton EL, Selin A, MacPhail C, Kahn K, Gómez-Olivé FX, Hughes JP, Pettifor A, Eshleman SH.

J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):315-322. doi: 10.1097/QAI.0000000000001793.

PMID:
29985265
5.

Antiretroviral drug use and HIV drug resistance among MSM and transgender women in sub-Saharan Africa.

Zhang Y, Fogel JM, Guo X, Clarke W, Breaud A, Cummings V, Hamilton EL, Ogendo A, Kayange N, Panchia R, Dominguez K, Chen YQ, Sandfort T, Eshleman SH.

AIDS. 2018 Jun 19;32(10):1301-1306. doi: 10.1097/QAD.0000000000001839.

6.

Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection.

Eshleman SH, Piwowar-Manning E, Sivay MV, Debevec B, Veater S, McKinstry L, Bekker LG, Mannheimer S, Grant RM, Chesney MA, Coates TJ, Koblin BA, Fogel JM.

J Clin Virol. 2018 Feb - Mar;99-100:67-70. doi: 10.1016/j.jcv.2018.01.003. Epub 2018 Jan 11.

7.

HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052.

Palumbo PJ, Fogel JM, Hudelson SE, Wilson EA, Hart S, Hovind L, Piwowar-Manning E, Wallis C, Papathanasopoulos MA, Morgado MG, Saravanan S, Tripathy S, Eron JJ, Gallant JE, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Pilotto JH, Kumwenda J, Akelo V, Godbole SV, Santos BR, Grinsztejn B, Panchia R, Chariyalertsak S, Makhema J, Badal-Faesen S, Chen YQ, Cohen MS, Eshleman SH.

J Acquir Immune Defic Syndr. 2018 Apr 15;77(5):484-491. doi: 10.1097/QAI.0000000000001623.

8.

Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052.

Palumbo PJ, Wilson EA, Piwowar-Manning E, McCauley M, Gamble T, Kumwenda N, Makhema J, Kumarasamy N, Chariyalertsak S, Hakim JG, Hosseinipour MC, Melo MG, Godbole SV, Pilotto JH, Grinsztejn B, Panchia R, Chen YQ, Cohen MS, Eshleman SH, Fogel JM.

PLoS One. 2017 May 8;12(5):e0177281. doi: 10.1371/journal.pone.0177281. eCollection 2017.

9.

Brief Report: Impact of Early Antiretroviral Therapy on the Performance of HIV Rapid Tests and HIV Incidence Assays.

Fogel JM, Piwowar-Manning E, Debevec B, Walsky T, Schlusser K, Laeyendecker O, Wilson EA, McCauley M, Gamble T, Tegha G, Soko D, Kumwenda J, Hosseinipour MC, Chen YQ, Cohen MS, Eshleman SH.

J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):426-430. doi: 10.1097/QAI.0000000000001421.

10.

Virologic outcomes in early antiretroviral treatment: HPTN 052.

Eshleman SH, Wilson EA, Zhang XC, Ou SS, Piwowar-Manning E, Eron JJ, McCauley M, Gamble T, Gallant JE, Hosseinipour MC, Kumarasamy N, Hakim JG, Kalonga B, Pilotto JH, Grinsztejn B, Godbole SV, Chotirosniramit N, Santos BR, Shava E, Mills LA, Panchia R, Mwelase N, Mayer KH, Chen YQ, Cohen MS, Fogel JM.

HIV Clin Trials. 2017 May;18(3):100-109. doi: 10.1080/15284336.2017.1311056. Epub 2017 Apr 7.

11.

Antiretroviral Drug Use in a Cross-Sectional Population Survey in Africa: NIMH Project Accept (HPTN 043).

Fogel JM, Clarke W, Kulich M, Piwowar-Manning E, Breaud A, Olson MT, Marzinke MA, Laeyendecker O, Fiamma A, Donnell D, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH, Chingono AH.

J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):158-165. doi: 10.1097/QAI.0000000000001229. Erratum in: J Acquir Immune Defic Syndr. 2018 Apr 15;77(5):e48.

12.

Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial.

Eshleman SH, Hudelson SE, Redd AD, Swanstrom R, Ou SS, Zhang XC, Ping LH, Piwowar-Manning E, Porcella SF, Sievers MF, Martens CA, Bruno D, Dukhovlinova E, McCauley M, Gamble T, Fogel JM, Sabin D, Quinn TC, Gunde L, Maliwichi M, Nhando N, Akelo V, Moyo S, Panchia R, Kumarasamy N, Chotirosniramit N, Melo MG, Pilotto J, Grinsztejn B, Mayer K, Chen YQ, Hughes JP, Cohen MS.

J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):112-116.

13.

Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial.

Fogel JM, Hudelson SE, Ou SS, Hart S, Wallis C, Morgado MG, Saravanan S, Tripathy S, Hovind L, Piwowar-Manning E, Sabin D, McCauley M, Gamble T, Zhang XC, Eron JJ, Gallant JE, Kumwenda J, Makhema J, Kumarasamy N, Chariyalertsak S, Hakim J, Badal-Faesen S, Akelo V, Hosseinipour MC, Santos BR, Godbole SV, Pilotto JH, Grinsztejn B, Panchia R, Mayer KH, Chen YQ, Cohen MS, Eshleman SH.

J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):304-9. doi: 10.1097/QAI.0000000000000951.

14.

Evaluation of postpartum HIV superinfection and mother-to-child transmission.

Redd AD, Wendel SK, Longosz AF, Fogel JM, Dadabhai S, Kumwenda N, Sun J, Walker MP, Bruno D, Martens C, Eshleman SH, Porcella SF, Quinn TC, Taha TE.

AIDS. 2015 Jul 31;29(12):1567-73. doi: 10.1097/QAD.0000000000000740.

15.

Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies.

Wang JW, Jagu S, Wu WH, Viscidi RP, Macgregor-Das A, Fogel JM, Kwak K, Daayana S, Kitchener H, Stern PL, Gravitt PE, Trimble CL, Roden RB.

Clin Vaccine Immunol. 2015 Jul;22(7):806-16. doi: 10.1128/CVI.00799-14. Epub 2015 May 13.

16.

Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061.

Chen I, Connor MB, Clarke W, Marzinke MA, Cummings V, Breaud A, Fogel JM, Laeyendecker O, Fields SD, Donnell D, Griffith S, Scott HM, Shoptaw S, del Rio C, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH.

J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):446-52. doi: 10.1097/QAI.0000000000000633.

17.

Determination of HIV Status in African Adults With Discordant HIV Rapid Tests.

Fogel JM, Piwowar-Manning E, Donohue K, Cummings V, Marzinke MA, Clarke W, Breaud A, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH.

J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):430-8. doi: 10.1097/QAI.0000000000000610.

18.

Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa.

Piwowar-Manning E, Fogel JM, Richardson P, Wolf S, Clarke W, Marzinke MA, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH.

J Clin Virol. 2015 Jan;62:75-9. doi: 10.1016/j.jcv.2014.11.023. Epub 2014 Nov 27.

19.

Low-level Viremia early in HIV infection.

Chen I, Cummings V, Fogel JM, Marzinke MA, Clarke W, Connor MB, Griffith S, Buchbinder S, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH.

J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):405-8. doi: 10.1097/QAI.0000000000000298.

20.

Failure to identify HIV-infected individuals in a clinical trial using a single HIV rapid test for screening.

Piwowar-Manning E, Fogel JM, Laeyendecker O, Wolf S, Cummings V, Marzinke MA, Clarke W, Breaud A, Wendel S, Wang L, Swanson P, Hackett J Jr, Mannheimer S, Del Rio C, Kuo I, Harawa NT, Koblin BA, Moore R, Blankson JN, Eshleman SH.

HIV Clin Trials. 2014 Mar-Apr;15(2):62-8. doi: 10.1310/hct1502-62.

21.

Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection.

Marzinke MA, Clarke W, Wang L, Cummings V, Liu TY, Piwowar-Manning E, Breaud A, Griffith S, Buchbinder S, Shoptaw S, del Rio C, Magnus M, Mannheimer S, Fields SD, Mayer KH, Wheeler DP, Koblin BA, Eshleman SH, Fogel JM.

Clin Infect Dis. 2014 Jan;58(1):117-20. doi: 10.1093/cid/cit672. Epub 2013 Oct 2.

22.

Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052).

Fogel JM, Wang L, Parsons TL, Ou SS, Piwowar-Manning E, Chen Y, Mudhune VO, Hosseinipour MC, Kumwenda J, Hakim JG, Chariyalertsak S, Panchia R, Sanne I, Kumarasamy N, Grinsztejn B, Makhema J, Pilotto J, Santos BR, Mayer KH, McCauley M, Gamble T, Bumpus NN, Hendrix CW, Cohen MS, Eshleman SH.

J Infect Dis. 2013 Nov 15;208(10):1624-8. doi: 10.1093/infdis/jit390. Epub 2013 Aug 1.

23.

Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants.

Fogel JM, Mwatha A, Richardson P, Brown ER, Chipato T, Alexandre M, Moodley D, Elbireer A, Mirochnick M, George K, Mofenson LM, Zwerski S, Coovadia HM, Eshleman SH.

Pediatr Infect Dis J. 2013 Apr;32(4):e164-9. doi: 10.1097/INF.0b013e31827f44ee.

24.

Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan children.

James MM, Wang L, Donnell D, Cousins MM, Barlow-Mosha L, Fogel JM, Towler WI, Agwu AL, Bagenda D, Mubiru M, Musoke P, Eshleman SH.

Pediatr Infect Dis J. 2012 Nov;31(11):e222-8. doi: 10.1097/INF.0b013e3182678c3f.

25.

Stavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants.

Fogel JM, Taha TE, Sun J, Hoover DR, Parsons TL, Kumwenda JJ, Mofenson LM, Fowler MG, Hendrix CW, Kumwenda NI, Eshleman SH, Mirochnick M.

J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):462-5.

26.

Organic osmolytes betaine, sorbitol and inositol are potent inhibitors of erythrocyte membrane ATPases.

Moeckel GW, Shadman R, Fogel JM, Sadrzadeh SM.

Life Sci. 2002 Oct 4;71(20):2413-24.

PMID:
12231402
27.

Racemic epinephrine in the treatment of croup: nebulization alone versus nebulization with intermittent positive pressure breathing.

Fogel JM, Berg IJ, Gerber MA, Sherter CB.

J Pediatr. 1982 Dec;101(6):1028-31. No abstract available.

PMID:
6754899

Supplemental Content

Loading ...
Support Center